TG Therapeutics | TGTX - Stock


TG Therapeutics reported $129.03M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Ardelyx USD 128.02M 110.29M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bayer EUR 12.34B 3M Dec/2025
Biogen USD 1.95B 219.1M Mar/2026
Corcept Therapeutics USD 12.89M 22K Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
J&J USD 14.58B 392M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Novartis USD 6.29B 17M Mar/2026
Novavax USD 11.46M 87K Mar/2026
PTC Therapeutics USD 75.57M 4.08M Mar/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 129.03M 3.44M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026